Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 66

1.

Population pharmacokinetics of naringin in total flavonoids of Drynaria fortunei (Kunze) J. Sm. in Chinese women with primary osteoporosis.

Wang JN, Jiang JJ, Xie YM, Wei X, Li JP, Duan JL, Xiong X.

Chin J Integr Med. 2012 Dec;18(12):925-33. doi: 10.1007/s11655-012-1296-0. Epub 2012 Dec 13.

PMID:
23239001
2.

Effect of naringenin in Qianggu capsule on population pharmacokinetics in Chinese women with primary osteoporosis.

Jiannong W, Junjie J, Yanming X, Xu W, Jianpeng L, Jingli D, Xin X.

J Tradit Chin Med. 2015 Apr;35(2):141-53.

3.

Phenylpropanoid and flavonoids from osteoprotective fraction of Drynaria fortunei.

Wang XL, Wang NL, Gao H, Zhang G, Qin L, Wong MS, Yao XS.

Nat Prod Res. 2010 Aug;24(13):1206-13. doi: 10.1080/14786410902991860.

PMID:
20645207
4.

Effects of eleven flavonoids from the osteoprotective fraction of Drynaria fortunei (KUNZE) J. SM. on osteoblastic proliferation using an osteoblast-like cell line.

Wang XL, Wang NL, Zhang Y, Gao H, Pang WY, Wong MS, Zhang G, Qin L, Yao XS.

Chem Pharm Bull (Tokyo). 2008 Jan;56(1):46-51.

6.

Osteogenic effects of flavonoid aglycones from an osteoprotective fraction of Drynaria fortunei--an in vitro efficacy study.

Wang X, Zhen L, Zhang G, Wong MS, Qin L, Yao X.

Phytomedicine. 2011 Jul 15;18(10):868-72. doi: 10.1016/j.phymed.2011.01.022. Epub 2011 Mar 5.

PMID:
21377852
7.
8.

Population pharmacokinetics of doxorubicin: establishment of a NONMEM model for adults and children older than 3 years.

Kontny NE, Würthwein G, Joachim B, Boddy AV, Krischke M, Fuhr U, Thompson PA, Jörger M, Schellens JH, Hempel G.

Cancer Chemother Pharmacol. 2013 Mar;71(3):749-63. doi: 10.1007/s00280-013-2069-1. Epub 2013 Jan 13.

PMID:
23314734
9.

[Effects of Drynaria total flavonoids on apoptosis of osteoblasts mediated by tumor necrosis factor-α].

Huang ZM, Ouyang GL, Xiao LB, Li NL, Gao HL, He Y, Huang Z, Huang XX.

Zhong Xi Yi Jie He Xue Bao. 2011 Feb;9(2):173-8. Chinese.

10.

Population pharmacokinetics study of remifentanil in Chinese adult patients determined by an LC-MS/MS method.

Zhang C, Zhang L, Zhang X, Yang L, Zhai S, Duan L.

Int J Clin Pharmacol Ther. 2008 Sep;46(9):477-88.

PMID:
18793578
11.

Quantitative determination of four compounds and fingerprint analysis in the rhizomes of Drynaria fortunei (Kunze) J. Sm.

Liu H, Zou S, Qi Y, Zhu Y, Li X, Zhang B.

J Nat Med. 2012 Apr;66(2):413-9. doi: 10.1007/s11418-011-0595-x. Epub 2011 Nov 16.

PMID:
22086672
12.

Pharmacokinetic evaluation of the vinorelbine-lapatinib combination in the treatment of breast cancer patients.

Rezai K, Urien S, Isambert N, Roche H, Dieras V, Berille J, Bonneterre J, Brain E, Lokiec F.

Cancer Chemother Pharmacol. 2011 Dec;68(6):1529-36. doi: 10.1007/s00280-011-1650-8. Epub 2011 Apr 26.

PMID:
21519841
13.

[Effect of Drynaria fortunei naringin on the total protein content and ultra-structure of human periodontal ligament cells].

Jiang JQ, Cai W, Wang ZC, Ding Y, Li XY.

Hua Xi Kou Qiang Yi Xue Za Zhi. 2010 Jun;28(3):330-3. Chinese.

14.

Unaltered etanercept pharmacokinetics with concurrent methotrexate in patients with rheumatoid arthritis.

Zhou H, Mayer PR, Wajdula J, Fatenejad S.

J Clin Pharmacol. 2004 Nov;44(11):1235-43.

PMID:
15496641
15.

Population pharmacokinetics of raltitrexed in patients with advanced solid tumours.

Blair EY, Rivory LP, Clarke SJ, McLachlan AJ.

Br J Clin Pharmacol. 2004 Apr;57(4):416-26.

16.

Time of drug administration, CYP3A5 and ABCB1 genotypes, and analytical method influence tacrolimus pharmacokinetics: a population pharmacokinetic study.

Musuamba FT, Mourad M, Haufroid V, Delattre IK, Verbeeck RK, Wallemacq P.

Ther Drug Monit. 2009 Dec;31(6):734-42. doi: 10.1097/FTD.0b013e3181bf8623.

PMID:
19855314
17.

[Research progress on Drynaria fortunei naringin on inflammation and bone activity].

Yin FM, Xiao LB, Zhang Y.

Zhongguo Gu Shang. 2015 Feb;28(2):182-6. Review. Chinese.

PMID:
25924506
18.
19.
20.

Pharmacokinetics of duloxetine hydrochloride enteric-coated tablets in healthy Chinese volunteers: a randomized, open-label, single- and multiple-dose study.

Zhao RK, Cheng G, Tang J, Song J, Peng WX.

Clin Ther. 2009 May;31(5):1022-36. doi: 10.1016/j.clinthera.2009.05.005.

PMID:
19539103

Supplemental Content

Support Center